Cleared Special

K093969 - ACUITY BREAK-AWAY GUIDE CATHETER

K093969 is the FDA 510(k) clearance for ACUITY BREAK-AWAY GUIDE CATHETER by Cardiac Pacemakers, Inc.. It is a Class 2 Cardiovascular device (product code DQY) cleared through the Special 510(k) pathway after a 72-day FDA review.

K093969 · Cardiac Pacemakers, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 2010
Decision
72d
Days
Class 2
Risk

K093969 is an FDA 510(k) clearance for the ACUITY BREAK-AWAY GUIDE CATHETER. Classified as Catheter, Percutaneous (product code DQY), Class II - Special Controls.

Submitted by Cardiac Pacemakers, Inc. (St Paul, US). The FDA issued a Cleared decision on March 5, 2010 after a review of 72 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1250 - the FDA cardiovascular device oversight framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Cardiac Pacemakers, Inc. devices

Submission Details

510(k) Number K093969 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 23, 2009
Decision Date March 05, 2010
Days to Decision 72 days
Submission Type Special
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
53d faster than avg
Panel avg: 125d · This submission: 72d
Pathway characteristics
Modification to existing cleared device.

Device Classification

Product Code DQY Catheter, Percutaneous
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1250
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DQY Catheter, Percutaneous

All 547
Devices cleared under the same product code (DQY) and FDA review panel - the closest regulatory comparables to K093969.
SCOUTPRO HEMOSTATIC VALVE
K101282 · Biotronik, Inc. · Jul 2010
PENUMBRA CATHERER 025
K100826 · Penumbra, Inc. · Jul 2010
CLEARWAY OTW MODEL 85912
K093431 · Atrium Medical Corp. · Apr 2010
ASAHI ZENYTEEX GUIDING CATHETER
K091188 · Asahi Intecc Co., Ltd. · Feb 2010
ARROW SELDINGER ARTERIAL CATHERIZATION DEVICES, MODELS EX SAC 00520
K093050 · Arrow Intl., Inc. · Dec 2009
SCOUTPRO 7F LONG CATHETERS
K093303 · Biotronik, Inc. · Nov 2009